Amber Specialty Pharmacy is now offering nemolizumab-ilto (Nemluvio, Galderma) for the treatment of prurigo nodularis in adults.
“We are thrilled to offer our patients access to Galderma’s cutting-edge medication for Prurigo Nodularis,” says Kristin Williams, president of Amber Specialty Pharmacy, in a news release. “This collaboration aligns with our commitment to providing the best possible care and improving the lives of those affected by rare and chronic conditions.”
Amber Specialty Pharmacy will begin offering the interluekoin (IL)-31 blocer immediately, For more information, visit www.AmberPharmacy.com or contact Amber Specialty Pharmacy’s customer service team at (888) 370-1724.
